| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Published online before print December 4, 2008
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Epigenetically Regulates Cell Differentiation and Exhibits Potential as a Therapeutic Target for Various Types of Cancers


From the Departments of Pathology,* and Cell Therapy,
Tokyo Medical University, Tokyo, Japan; and Department of Surgery,
Kosei Chuo General Hospital
Heterochromatin protein 1 (HP1) is a chromosomal protein that participates in both chromatin packaging and gene silencing. Three HP1 isoforms (
, β, and
) occur in mammals, but their functional differences are still incompletely understood. In this study, we found that HP1
levels are decreased during adipocyte differentiation, whereas HP1
and β levels are expressed constitutively during adipogenesis in cultured preadipocyte cells. In addition, ectopic overexpression of HP1
inhibited adipogenesis. Furthermore, we did not detect any HP1
protein in the differentiated cells of various normal human tissues. These results suggest that the loss of HP1
is required for cell differentiation to occur. On the other hand, the methylation levels of lysine 20 (K20) on histone H4 showed a significant correlation with HP1
expression in both these preadipocyte cells and normal tissue samples. However, all cancer tissues examined were positive for HP1
but were often negative for trimethylated histone H4 K20. Thus, a dissociation of the correlation between HP1
expression and histone H4 K20 trimethylation may reflect the malfunction of epigenetic control. Finally, suppression of HP1
expression restrained cell growth in various cancer-derived cell lines, suggesting that HP1
may be an effective target for gene therapy against various human cancers. Taken together, our results demonstrate the novel function of HP1
in the epigenetic regulation of both cell differentiation and cancer development.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |